Auris Medical Resumes Enrollment in TACTT3 Phase 3 Trial of Keyzilen in Acute and Post-Acute Tinnitus Biotech Investing
Laguna Completes Definitive Equity Agreement with Carlsbad Naturals for Nano-Amplified CBD Water Biotech Investing
BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia Biotech Investing
Ritter Pharmaceuticals Announces Collaboration with University of Nebraska to Explore Development of Microbiome Therapeutics in Metabolic Syndrome Biotech Investing
